AFFY - Quotes - International Business Times

Affymax ends part of Hematide development program

(NEW YORK)Affymax Inc. and Japanese partner Takeda Pharmaceutical Co. said Thursday they will cut part of their development program for the anemia drug candidate Hematide and continue focusi...READ MORE

Aug 28, 2008 4:23PM

Keywords: AFFY, AMGN, JNJ

Affymax wavers on forecast of Hematide approval

(NEW YORK)Shares of Affymax Inc. fluctuated wildly Wednesday after an analyst predicted success for the company's drug candidate Hematide as a treatment for anemia caused by kidney disease.READ MORE

Jul 02, 2008 5:39PM

Keywords: AFFY, AMGN, JNJ, NKTR

Affymax Reports Wider Loss in 4Q

(PALO ALTO, Calif.)Biotechnology company Affymax Inc. said Thursday it reported a wider loss in the fourth quarter despite a big boost in revenue resulting a partnership with another drug company to ...READ MORE

Mar 13, 2008 8:02AM

Keywords: AFFY

Affymax Shares Fall on Takeda-Amgen Deal

(NEW YORK)Shares of biotechnology company Affymax Inc. fell Tuesday after its partner Takeda Pharmaceutical signed an additional agreement with potential rival Amgen Inc.READ MORE

Feb 05, 2008 6:28PM

Keywords: AFFY, AMGN

AMGEN	-14.60	47.76
GILEAD SCIENCES	-22.40	38.28
GENENTECH INC	+7.00	81.50
CELGENE CP	-27.00	52.71
BIOGEN IDEC INC	-41.40	42.46

AFFYMAX INC. AFFY (NASDAQ)

Affymax ends part of Hematide development program

Affymax wavers on forecast of Hematide approval

Affymax Reports Wider Loss in 4Q

Affymax Shares Fall on Takeda-Amgen Deal

Top Competitors